Novel lipoprotein density profiling in healthy dogs of various breeds, healthy miniature schnauzers, and miniature schnauzers with hyperlipidemia

BMC Veterinary Research

Jörg M Steiner³  Jan S Suchodolski³  Ronald D Macfarlane²  Rosemary L Walzem¹  Paul J Cammarata²  Panagiotis G Xenoulis³ 

[1] Department of Nutrition and Food Science and Department of Poultry Science, Texas A&M University, 2253 TAMU, College Station, Texas 77843, USA;Laboratory for Cardiovascular Chemistry, Department of Chemistry, Texas A&M University, 3255 TAMU, College Station 77842, USA;Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, 4474 TAMU, College Station, TX 77843, USA

关键词: Disease;    Ultracentrifugation;    NaBiY;    NaBiEDTA;    Lipoprotein fingerprinting;    Lipemia;    Hypertriglyceridemia;    Canine;   

Others  :  1119591
DOI  :  10.1186/1746-6148-9-47

 received in 2012-12-03, accepted in 2013-02-26,  发布年份 2013

【 摘 要 】

Background

Despite the importance of abnormalities in lipoprotein metabolism in clinical canine medicine, the fact that most previously used methods for lipoprotein profiling are rather laborious and time-consuming has been a major obstacle to the wide clinical application and use of lipoprotein profiling in this species. The aim of the present study was to assess the feasibility of a continuous lipoprotein density profile (CLPDP) generated within a bismuth sodium ethylenediaminetetraacetic acid (NaBiEDTA) density gradient to characterize and compare the lipoprotein profiles of healthy dogs of various breeds, healthy Miniature Schnauzers, and Miniature Schnauzers with primary hypertriacylglycerolemia. A total of 35 healthy dogs of various breeds with serum triacylglycerol (TAG) and cholesterol concentrations within their respective reference intervals were selected for use as a reference population. Thirty-one Miniature Schnauzers with serum TAG and cholesterol concentrations within their respective reference intervals and 31 Miniature Schnauzers with hypertriacylglyceridemia were also included in the study.

Results

The results suggest that CLPDP using NaBiEDTA provides unique diagnostic information in addition to measurements of serum TAG and cholesterol concentrations and that it is a useful screening method for dogs with suspected lipoprotein metabolism disorders. Using the detailed and continuous density distribution information provided by the CLPDP, important differences in lipoprotein profiles can be detected even among dogs that have serum TAG and cholesterol concentrations within the reference interval. Miniature Schnauzers with serum TAG and cholesterol concentrations within the reference interval had significantly different lipoprotein profiles than dogs of various other breeds. In addition, it was further established that specific lipoprotein fractions are associated with hypertriacylglyceridemia in Miniature Schnauzers.

Conclusions

The results of the present study suggest that density gradient ultracentrifugation using NaBiEDTA is a useful screening method for the study of lipoprotein profiles in dogs. Therefore, this method could potentially be used for diagnostic purposes for the separation of dogs suspected of having lipoprotein abnormalities from healthy dogs.

【 授权许可】

   
2013 Xenoulis et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

【 参考文献 】

• [1]Lewis LA, Page IH: Studies on lipoproteins in dog serum. Fed Proc 1949, 8:96-97.
• [2]Lewis LA, Green AA, Page IH: Ultracentrifuge lipoprotein pattern of serum of normal, hypertensive and hypothyroid animals. Am J Physiol 1952, 171:391-400.
• [3]Solyom AR, Bradford H, Furman RH: Apolipoprotein and lipid distribution in canine serum lipoproteins. Biochim Biophys Acta 1971, 229:471-483.
• [4]Mahley RW, Weisgraber KH: Canine lipoproteins and atherosclerosis. I. Isolation and characterization of plasma lipoproteins from control dogs. Circ Res 197435:713-721.
• [5]Rogers WA, Donovan EF, Kociba GJ: Lipids and lipoproteins in normal dogs and in dogs with secondary hyperlipoproteinemia. J Am Vet Med Assoc 1975, 166:1092-1100.
• [6]Whitney MS, Boon GD, Rebar AH, Ford RB: Effects of acute pancreatitis on circulating lipids in dogs. Am J Vet Res 1987, 48:1492-1497.
• [7]Chikamune T, Katamoto H, Ohashi F, Shimada Y: Serum lipid and lipoprotein concentrations in obese dogs. J Vet Med Sci 1995, 57:595-598.
• [8]Chikamune T, Katamoto H, Nomura K, Ohashi F: Lipoprotein profile in canine pancreatitis induced with oleic acid. J Vet Med Sci 1998, 60:413-421.
• [9]Jeusette IC, Lhoest ET, Istasse LP, Diez M: Influence of obesity on plasma lipid and lipoprotein concentrations in dogs. Am J Vet Res 2005, 66:81-86.
• [10]Whitney MS, Boon GD, Rebar AH, Story JA, Bottoms JD: Ultracentrifugal and electrophoretic characteristics of the plasma lipoproteins of Miniature Schnauzer dogs with idiopathic hyperlipoproteinemia. J Vet Intern Med 1993, 7:253-260.
• [11]Pasquini A, Luchetti E, Cardini G: Plasma lipoprotein concentrations in the dog: the effects of gender, age, breed and diet. J Anim Physiol Anim Nutr (Berl) 2008, 92:718-722.
• [12]Hosken BD, Cockrill SL, Macfarlane RD: Metal ion complexes of EDTA: a solute system for density gradient ultracentrifugation analysis of lipoproteins. Anal Chem 2005, 77:200-207.
• [13]Larner CD, Henriquez RR, Johnson JD, Macfarlane RD: Developing high performance lipoprotein density profiling for use in clinical studies relating to cardiovascular disease. Anal Chem 2011, 83:8524-8530.
• [14]Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK, Hindy G, Hólm H, Ding EL, Johnson T, Schunkert H, Samani NJ, Clarke R, Hopewell JC, Thompson JF, Li M, Thorleifsson G, Newton-Cheh C, Musunuru K, Pirruccello JP, Saleheen D, Chen L, Stewart A, Schillert A, Thorsteinsdottir U, Thorgeirsson G, Anand S, Engert JC, Morgan T, Spertus J: Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 2012, 380:572-580.
• [15]de Graaf AA, van Schalkwijk DB: Computational models for analyzing lipoprotein profiles. Clin Lipidol 2011, 6:25-33.
• [16]Xenoulis PG, Suchodolski JS, Ruaux CG, Steiner JM: Association between serum triglyceride and canine pancreatic lipase immunoreactivity concentrations in Miniature Schnauzers. J Am Anim Hosp Assoc 2010, 46:229-234.
• [17]Xenoulis PG, Levinski MD, Suchodolski JS, Steiner JM: Serum triglyceride concentrations in Miniature Schnauzers with and without a history of probable pancreatitis. J Vet Intern Med 2011, 25:20-25.
• [18]Musunuru K, Orho-Melander M, Caulfield MP, Li SG, Salameh WA, Reitz RE, Berglund G, Hedblad B, Engström G, Williams PT, Kathiresan S, Melander O, Krauss RM: Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk. Arterioscler Thromb Vasc Biol 2009, 29:1975-1980.
• [19]Krauss RM: Lipoprotein subfractions and cardiovascular disease risk. Curr Opin Lipidol 2010, 21:305-311.
• [20]Xenoulis PG, Steiner JM: Lipid metabolism and hyperlipidemia in dogs. Vet J 2010, 183:12-21.
• [21]Xenoulis PG, Suchodolski JS, Levinski MD, Steiner JM: Investigation of hypertriglyceridemia in healthy miniature schnauzers. J Vet Intern Med 2007, 21:1224-1230.
• [22]Xenoulis PG, Suchodolski JS, Levinski MD, Steiner JM: Serum liver enzyme activities in healthy Miniature Schnauzers with and without hypertriglyceridemia. J Am Vet Med Assoc 2008, 232:63-67.
• [23]Huth SP, Relford RL, Steiner JM, Strong-Townsend MI, Williams DA: Analytical validation of an ELISA for the measurement of canine pancreas-specific lipase. Vet Clin Pathol 2010, 39:346-353.
• [24]Johnson JD, Bell NJ, Donahoe EL, Macfarlane RD: Metal ion complexes of EDTA as solutes for density gradient ultracentrifugation: influence of metal ions. Anal Chem 2005, 77:7054-7061.
• [25]Li KC: Sliced inverse regression for dimension reduction. J Am Stat Assoc 1991, 86:316-327.
• [26]Guerin M, Bruckert E, Dolphin PJ, Turpin G, Chapman MJ: Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia. Arterioscler Thromb Vasc Biol 1996, 16:763-772.
• [27]Schmitz G, Assmann G: Isolation of human serum HDL1 by zonal ultracentrifugation. J Lipid Res 1982, 23:903-910.
• [28]Chapman MJ: Animal lipoproteins: chemistry, structure, and comparative aspects. J Lipid Res 1980, 21:789-853.